Veraxa Biotech is trading at $0.90, down 5.47%, in a move consistent with the supplied biotech-sector context. - No new company-specific announcement was identified for November 6; the company’s latest listed releases are from October. - The supplied context reports XBI down 5.19% during the regular session; broader technology-market pressure was also reported after Thursday’s sell-off. - No trading volume or activity data was provided.